**Publications**

**Mobility network modeling explains higher SARS-CoV-2 infection rates among disadvantaged groups and informs reopening strategies.** *medRxiv*. Chang S, Pierson E, Koh PW, Gerardin J, Redbird B, Grusky D, Leskovec J (2020)

**Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next five years**. *Science*. Saad-Roy C, Wagner C, Baker R, Morris S, Farrar J, Graham A, Levin S, Mina M, Metcalf J, Grenfell B (2020)

**Epidemiology and transmission dynamics of COVID-19 in two Indian states.** *Science*. Laxminarayan R, Wahl B, Reddy Dudala S, Gopal K, Mohan C, Neelima S, Jawahar Reddy KS, Radhakrishnan J, Lewnard J (2020)

**Cocooning is essential to relaxing social distancing**. *medRxiv*. Wang X, Du Z, Huang G, Pasco R, Fox S, Galvani A, Pignone M, Johnston SC, Meyers L (2020)

**Impact of Social Distancing Measures on COVID-19 Healthcare Demand in Central Texas. ***medRxiv*. Wang X, Pasco R, Du Z, Petty M, Fox S, Galvani A, Pignone M, Johnston SC, Meyers L (2020)

**The imperative for universal healthcare to curtail the COVID-19 outbreak in the USA.** *EClinicalMedicine*. Galvani A, Parpia A, Pandey A, Zimmer C, Kahn J, Fitzpatrick M (2020)

**COVID-19 on the African Continent.** *The Lancet Infectious Diseases*. Wells C, Stearns J, Lutumba P, Galvani A (2020)

**Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities.** *medRxiv*. Du Z, Xu X, Wang L, Fox S, Cowling B, Galvani A, Meyers L (2020)

**Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.** *CMAJ*. Abdollahi E, Champredon D, Langley J, Galvani A, Moghadas S (2020)

**Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA.** *The Lancet Infectious Diseases*. Wells C, Fitzpatrick M, Sah P, Shoukat A, Pandey A, El-Sayed A, Singer B, Moghadas S, Galvani A (2020)

**Projecting demand for critical care beds during COVID-19 outbreaks in Canada.** *CMAJ, 192(19):E489-496*. Shoukat A, Wells C, Langley J, Singer B, Galvani A, Moghadas S (2020)

**Implementation of Syringe Services Programs to Prevent Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.** *Clinical Infectious Diseases, 70(6):1096-1102*. Goedel W, King M, Lurie M, Galea S, Townsend J, Galvani A, Friedman S, Marshall B (2020)

**Projecting hospital utilization during the COVID-19 outbreaks in the United States**. *PNAS, 117(16):9122-9126*. Moghadas S, Shoukat A, Fitzpatrick M, Wells C, Sah P, Pandey A, Sachs J, Wang Z, Meyers L, Singer B, Galvani A (2020)

**Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak**. *PNAS, 117(13):7504-7509*. Wells C, Sah P, Moghadas S, Pandey A, Shoukat A, Wang Y, Wang Z, Meyers L, Singer B, Galvani A (2020)

**Pooling RT-PCR or NGS samples has the potential to cost-effectively generate estimates of COVID-19 prevalence in resource-limited environments.** *medRxiv*. Narayanan K, Frost I, Heidarzadeh A, Tseng K, Banerjee S, John J, Laxminarayan R (2020)

**Who is at the highest risk for COVID-19 in India? An analysis of health, healthcare access, and socioeconomic indicators at the district level.** *medRxiv*. Nandi A, Balasubramanian, Laxminarayan R (2020)

**Risks to Children under-five in India from COVID-19.** *medRxiv*. Frost I, Tseng K, Hauck S, Kappor G, Sriram A, Nandi A, Laxminarayan R (2020)

**Childhood vaccinations and adult schooling attainment: Long-term evidence from India's Universal Immunization Programme.** *Social Science & Medicine, 250:112885*. Nandi A, Kumar S, Shet A, Bloom DE, Laxminarayan R (2020)

**Covid-19 risks and response in South Asia.** *BMJ 2020;368:m1190. *Bhutta Z, Basnyat B, Saha S, Laxminarayan R (2020)

**On Accelerated Testing for COVID-19 Using Group Testing.*** arXiv.* Narayanan K, Heidarzadeh A, Laxminarayan R (2020)

**Childhood vaccines and antibiotic use in low-and middle-income countries.** *Nature, 581:94-99*. Lewnard J, Lo N, Arinaminpathy N, Frost I, Laxminarayan R (2020)

**Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? ***Indian Pediatrics. *Laxminarayan R, John TJ* (2020)*

**COVID-19: Mathematical Modeling & the Transmission Dynamics of SARS-CoV-2 in Cali, Colombia: Implications to a 2020 Outbreak & public health preparedness. ***Letters in Biomathematics, May.* Mubayi A, Akman O, Banerjee M, Paredes M, Rojas J (2020)

**COVID-19: Regression Approaches of Survival Data in the Presence of Competing Risks: an Application to COVID-19.** *Letters in Biomathematics, May*. Ghosh S, Samanta GP, Mubayi A (2020)

**Designing Effective and Practical Interventions to Contain Epidemics.** *Proceedings of the 19th International Conference on Autonomous Agents and Multiagent Systems, 1187-1195*. Sambaturu P, Adhikari B, Prakash BA, Venkatramanan S, Vullikanti A (2020)

**Networked epidemiology for COVID-19.** *SIAM News**. Forthcoming. *Chen J, Eubank S, Levin S, Mortveit H, Venkataramanan S, Vullikanti A, Marathe M (2020)

**Explaining the "bomb-like" dynamics of COVID-19 with modeling and implications for policy.** *CDC MinD-Healthcare Program. To be submitted. *Lin G, Strauss AT, Pinz M, Martinez DA, Tseng KT, Schueller E, Gatalo O, Yang Y, Levin S, Klein EY (2020)

**Computational challenges and opportunities for forecasting epidemic dynamics using network models.** *Submitted. *Marathe M, Vullikanti A, Rosenkrantz D, Ravi SS, Stearns R, Levin S (2020)

**Optimal, near-optimal, and robust epidemic control.** *Environmental and Resource Economics. Submitted. *Morris D, Rossine F, Plotkin J, Levin S (2020)

**Methods for Rapid Mobility Estimation to Support Outbreak Response. ***Health Security, 18:1. *Telionis PA, Corbett P, Venkatramanan S, Lewis B (2020)

**Evolution of an asymptomatic first stage of infection in a heterogeneous population. ***PNAS. Submitted. *Saad-Roy C, Grenfell B, Levin S, Van den Driessche P, Wingreen N (2020)

**Dynamics in a simple evolutionary-epidemiological model for the evolution of an initial asymptomatic infection stage.** *PNAS. 117(21):11541-50. *Saad-Roy C, Wingreen N, Levin S, Grenfell B (2020)

**Staggered Release Policies for COVID-19 Control: Costs and Benefits of Sequentially Relaxing Restrictions by Age. ***arXiv*. Zhao H, Feng Z, Castillo-Chavez C, Levin S (2020)

**Commentary on Ferguson, et al, "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand.** *Bulletin of Mathematical Biology 82*. Eubank S, Eckstrand I, Lewis B, Venkatramanan S, Marathe M, Barrett C (2020)

**Evaluating the impact of international airline suspensions on the early global spread of COVID-19. ***medRxiv.* Adiga A, et al (2020)

**Presentations**

**Uncertainty & Precision in Math Modeling to Mitigate the Threat of COVID-19**. *Mathematical Models on Epidemiology in Connection with COVID-19*, Dept of Mathematics, Vellore Institute of Technology, TN, India. Mubayi A (June 2020)

**Underreporting, Preparedness, and Silent Typhoid Marys: A Cautionary Tale of Modeling COVID Dynamics**. *COVID-19 Modeling Webinar Series*, Indian Institute of Public Health, Gandhinagar, India. Mubayi A (June 2020)

**Responding to the COVID-19 Pandemic: Role of Computing and Data Science.** *IIT Madras Leadership Lecture Series*. Marathe M (May 2020)

**Tackling the COVID-19 Crisis.** *UVA Research virtual panel.* Marathe M (May 2020)

**Computational and Statistical Tools to Control a Pandemic.** *Theoretically Speaking Series, Simons Institute for the Theory of Computing*. Team members on the virtual panel: Moitra A, Marathe M, Vullikanti A (May 2020)

**Computational Science for Real-time COVID-19 Response.** *ACM India Industry Webinar*. Marathe M (Apr 2020)

**Recommendations for Improving Science During Crisis**. *AAAS Annual Meeting.* Colwell R (Feb 2020)